[Hemodilution and infusion therapy for hypovolemic shock. Clinical physiological and pharmacological aspects].
Hypovolemic shock is not a form of disease and can be subdivided into four special types with varying therapeutic demands. The decisive approach in the therapy of hypovolemic shock is to initially attain normovolemia by rapid administration of volume replacement agents in the sense of controlled hemodilution. This allows an adequate increase in the cardiac output resulting in delivery of sufficient oxygen to tissues. In the following article the limits of intervention will be described and the advantages and disadvantages of these measures for patients suffering from hypovolemic shock will be critically considered.
Adams
H A
HA
Stabsstelle für Interdisziplinäre Notfall- und Katastrophenmedizin, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover. adams.ha@mh-hannover.de
D001811:Blood Volume Determination; D002302:Cardiac Output / Q000502:physiology; D000077324:Crystalloid Solutions; D005440:Fluid Therapy; D006438:Hemodilution; D006801:Humans; D007262:Infusions, Intravenous; D007552:Isotonic Solutions / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use*; D012769:Shock / Q000209:etiology / Q000628:therapy*; D009626:Terminology as Topic
D000077324:Crystalloid Solutions; D007552:Isotonic Solutions; D010952:Plasma Substitutes